BIOL

Biolase (BIOL)

Biolase Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:BIOL

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/14	05:30	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:BIOL	Biolase Inc
2024/05/14	05:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BIOL	Biolase Inc
2024/05/07	05:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BIOL	Biolase Inc
2024/03/08	20:31	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:BIOL	Biolase Inc
2024/03/05	20:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BIOL	Biolase Inc
2024/02/28	06:14	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BIOL	Biolase Inc
2024/02/24	06:05	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:BIOL	Biolase Inc
2024/02/22	06:39	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:BIOL	Biolase Inc
2024/02/21	21:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BIOL	Biolase Inc
2024/02/16	07:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BIOL	Biolase Inc
2024/02/15	03:10	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:BIOL	Biolase Inc
2024/02/14	14:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:BIOL	Biolase Inc
2024/02/14	10:03	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:BIOL	Biolase Inc
2024/02/09	22:44	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:BIOL	Biolase Inc
2024/02/07	20:11	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:BIOL	Biolase Inc
2024/02/07	20:04	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BIOL	Biolase Inc
2024/01/31	11:57	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:BIOL	Biolase Inc
2024/01/30	07:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BIOL	Biolase Inc
2024/01/29	20:30	PR Newswire (US)	BIOLASE REPORTS UNAUDITED REVENUE GROWTH FOR FULL YEAR 2023 AND PROVIDES OUTLOOK FOR FULL YEAR 2024	NASDAQ:BIOL	Biolase Inc
2024/01/25	07:21	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:BIOL	Biolase Inc
2024/01/19	20:09	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	NASDAQ:BIOL	Biolase Inc
2024/01/09	06:05	PR Newswire (US)	BIOLASE ENHANCES EDUCATION OFFERINGS IN 2024 DUE TO INCREASING DEMAND OF DENTAL LASER COURSES THROUGHOUT 2023	NASDAQ:BIOL	Biolase Inc
2024/01/04	06:05	PR Newswire (US)	BIOLASE RECEIVES SECOND TOP WORKPLACES 2023 AWARD	NASDAQ:BIOL	Biolase Inc
2023/12/30	06:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BIOL	Biolase Inc
2023/12/27	07:22	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	NASDAQ:BIOL	Biolase Inc
2023/12/21	04:13	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	NASDAQ:BIOL	Biolase Inc
2023/12/15	06:05	PR Newswire (US)	BIOLASE RECEIVES TOP WORKPLACES 2023 AWARD	NASDAQ:BIOL	Biolase Inc
2023/12/13	06:05	PR Newswire (US)	BIOLASE Successfully Concludes Waterlase iPlus All Tissue Laser Trial	NASDAQ:BIOL	Biolase Inc
2023/12/08	23:25	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BIOL	Biolase Inc
2023/12/08	23:23	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:BIOL	Biolase Inc